RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

Target & Classification

Virus:

EBOVEbola virus

Type:

Live attenuated vaccine

Diseases:

Ebola Virus Disease

Max Phase:

Phase 2

Phase 1

Phase 2

Phase 3

Approved

NCT ID	Phase	Disease / Condition
NCT02296983	Phase 1	Ebola Virus Disease
NCT02287480	Phase 2	Ebola Virus Disease